Skip to content

Pacemaker 208S

by Elema-Schonander, Inc.

510(k) K770005

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK770005 Date24 Feb 1977ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DXY
Device Class
Class III
Regulation
21 CFR Part 870.3610
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Pacemaker 208S is an Implantable Pacemaker Pulse-Generator, a Class III medical device designed to provide a periodic electrical pulse to stimulate the heart when intrinsic conduction is insufficient. It includes a power supply and electronic circuitry to regulate cardiac rhythm in patients with bradycardia or other conduction disorders.

This device is intended for implantable use under sterile conditions and is classified as single-use per regulatory submission. It adheres to FDA 510(k) clearance (K770005) under regulation 870.3610, with no noted MRI safety restrictions. Supplied as a sterile, pre-packaged unit, it requires surgical implantation by a qualified healthcare professional and is regulated under the Cardiovascular Device Advisory Committee.

Other devices from Elema-Schonander, Inc.

See all devices from Elema-Schonander, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary clinical purpose of the Pacemaker 208S, and how does it function in the body?

    The Pacemaker 208S is designed to treat patients with bradycardia or conduction disorders by delivering periodic electrical pulses to stimulate the heart when its natural rhythm is insufficient. It contains a power supply and electronic circuitry to regulate cardiac rhythm, ensuring consistent contractions when the heart’s intrinsic conduction system fails.

  • Is the Pacemaker 208S intended for reuse, or is it meant to be implanted as a single-use device?

    The Pacemaker 208S is classified as a single-use device per its regulatory submission, meaning it is intended for one-time surgical implantation and should not be reused. This aligns with its sterile, pre-packaged presentation for clinical use.

  • How is the Pacemaker 208S supplied, and what precautions should be taken during handling?

    The device is supplied as a sterile, pre-packaged unit, ensuring it meets surgical implantation standards. Since it is implanted under sterile conditions, healthcare professionals must adhere to aseptic techniques during handling to prevent contamination before or during the procedure.

  • Are there any known restrictions on using the Pacemaker 208S in environments with MRI machines?

    The device data does not specify any MRI safety restrictions for the Pacemaker 208S, meaning it may not be explicitly labeled as MRI-compatible or unsafe. However, clinicians should consult the full labeling or manufacturer guidelines to confirm compatibility before exposing patients to MRI environments.

  • What regulatory pathway was followed for the FDA clearance of the Pacemaker 208S, and which advisory committee reviewed it?

    The Pacemaker 208S received FDA clearance through a Traditional 510(k) pathway (K770005) under regulation 870.3610, with a decision of Substantially Equivalent (SESE). Its review was conducted by the Cardiovascular Device Advisory Committee (CV), reflecting its classification as an Implantable Pacemaker Pulse-Generator.